[144] Klaviyo, Inc. SEC Filing
Klaviyo, Inc. (KVYO) reported a Form 144 notice indicating an intended sale of 7,105 common shares with an aggregate market value of $223,310.15, representing part of the issuer's 116,897,730 outstanding shares. The shares are scheduled for sale approximately on 08/18/2025 on the NYSE. The filer acquired the shares as restricted stock units on 08/15/2025 and lists payment as N/A. The filing also discloses two prior 10b5-1 sales by Stephen Rowland of 7,079 shares on 07/15/2025 (gross proceeds $223,446.27) and 06/16/2025 (gross proceeds $244,619.43).
Klaviyo, Inc. (KVYO) ha presentato un avviso Form 144 relativo all'intenzione di vendere 7.105 azioni ordinarie per un valore di mercato complessivo di $223.310,15, pari a una parte delle 116.897.730 azioni in circolazione dell'emittente. Le azioni sono previste in vendita approssimativamente il 18/08/2025 sulla NYSE. Il dichiarante ha acquisito le azioni come restricted stock units il 15/08/2025 e indica il pagamento come N/A. La comunicazione riporta inoltre due vendite precedenti ai sensi del piano 10b5-1 effettuate da Stephen Rowland: 7.079 azioni il 15/07/2025 (proventi lordi $223.446,27) e il 16/06/2025 (proventi lordi $244.619,43).
Klaviyo, Inc. (KVYO) presentó un aviso Form 144 que indica la intención de vender 7.105 acciones comunes por un valor de mercado agregado de $223.310,15, representando una parte de las 116.897.730 acciones en circulación del emisor. Las acciones están programadas para su venta aproximadamente el 18/08/2025 en la NYSE. El declarante adquirió las acciones como restricted stock units el 15/08/2025 y señala el pago como N/A. La presentación también revela dos ventas previas bajo 10b5-1 realizadas por Stephen Rowland de 7.079 acciones el 15/07/2025 (ingresos brutos $223.446,27) y el 16/06/2025 (ingresos brutos $244.619,43).
Klaviyo, Inc. (KVYO)는 Form 144 통지서를 제출하여 총 시가가 $223,310.15인 7,105 보통주를 매각할 예정임을 알렸으며, 이는 발행사의 116,897,730 유통 주식의 일부를 차지합니다. 해당 주식은 약 2025-08-18에 NYSE에서 매각될 예정입니다. 제출인은 해당 주식을 restricted stock units으로 2025-08-15에 취득했으며 지급은 N/A로 기재했습니다. 또한 제출서에는 Stephen Rowland가 시행한 이전의 10b5-1 매각 두 건이 기재되어 있는데, 각각 2025-07-15에 7,079주(총수익 $223,446.27)와 2025-06-16에 7,079주(총수익 $244,619.43)입니다.
Klaviyo, Inc. (KVYO) a déposé un avis Form 144 indiquant son intention de vendre 7 105 actions ordinaires pour une valeur marchande totale de $223 310,15, représentant une partie des 116 897 730 actions en circulation de l'émetteur. Les actions devraient être vendues aux alentours du 18/08/2025 sur le NYSE. Le déclarant a acquis les actions sous forme de restricted stock units le 15/08/2025 et indique le paiement comme N/A. Le dépôt divulgue également deux ventes antérieures suivant le mécanisme 10b5-1 effectuées par Stephen Rowland : 7 079 actions le 15/07/2025 (produits bruts $223 446,27) et le 16/06/2025 (produits bruts $244 619,43).
Klaviyo, Inc. (KVYO) meldete ein Form 144, das den geplanten Verkauf von 7.105 Stammaktien mit einem Gesamtmarktwert von $223.310,15 ankündigt, was einen Teil der 116.897.730 ausstehenden Aktien des Emittenten darstellt. Die Aktien sollen voraussichtlich am 18.08.2025 an der NYSE verkauft werden. Der Einreicher hat die Aktien am 15.08.2025 als restricted stock units erworben und gibt die Zahlung als N/A an. Die Einreichung offenbart außerdem zwei frühere 10b5-1-Verkäufe von Stephen Rowland über 7.079 Aktien am 15.07.2025 (Bruttoerlös $223.446,27) und am 16.06.2025 (Bruttoerlös $244.619,43).
- Planned sale disclosed under Rule 144, providing transparency about insider liquidity
- Shares were acquired as Restricted Stock Units (08/15/2025), clearly describing acquisition type
- Prior 10b5-1 sales disclosed (07/15/2025 and 06/16/2025) indicating use of pre-established trading arrangements
- None.
Insights
TL;DR: Routine insider notice showing planned sale of 7,105 RSU-derived shares under Rule 144; prior 10b5-1 executions noted.
The Form 144 for KVYO documents an intended sale of 7,105 common shares valued at $223,310.15 and confirms the shares were acquired as restricted stock units on 08/15/2025. The filing references past 10b5-1 sales by Stephen Rowland totaling 14,158 shares in June and July 2025 with stated gross proceeds. For investors, this is a standard disclosure of insider liquidity and not an operational or financial statement of company performance. The information is factual and limited to share counts, values, acquisition method, and sale timing.
TL;DR: Disclosure aligns with Rule 144 and 10b5-1 practices; statement includes insider representation about absence of undisclosed material information.
The notice includes the required representation that the seller is unaware of undisclosed material adverse information and cites reliance on a trading plan in prior sales (10b5-1). It documents acquisition via RSUs and lists broker details for the planned sale. This filing is procedural and reflects compliance with securities-sale reporting obligations rather than a governance change or event with direct company-level implications.
Klaviyo, Inc. (KVYO) ha presentato un avviso Form 144 relativo all'intenzione di vendere 7.105 azioni ordinarie per un valore di mercato complessivo di $223.310,15, pari a una parte delle 116.897.730 azioni in circolazione dell'emittente. Le azioni sono previste in vendita approssimativamente il 18/08/2025 sulla NYSE. Il dichiarante ha acquisito le azioni come restricted stock units il 15/08/2025 e indica il pagamento come N/A. La comunicazione riporta inoltre due vendite precedenti ai sensi del piano 10b5-1 effettuate da Stephen Rowland: 7.079 azioni il 15/07/2025 (proventi lordi $223.446,27) e il 16/06/2025 (proventi lordi $244.619,43).
Klaviyo, Inc. (KVYO) presentó un aviso Form 144 que indica la intención de vender 7.105 acciones comunes por un valor de mercado agregado de $223.310,15, representando una parte de las 116.897.730 acciones en circulación del emisor. Las acciones están programadas para su venta aproximadamente el 18/08/2025 en la NYSE. El declarante adquirió las acciones como restricted stock units el 15/08/2025 y señala el pago como N/A. La presentación también revela dos ventas previas bajo 10b5-1 realizadas por Stephen Rowland de 7.079 acciones el 15/07/2025 (ingresos brutos $223.446,27) y el 16/06/2025 (ingresos brutos $244.619,43).
Klaviyo, Inc. (KVYO)는 Form 144 통지서를 제출하여 총 시가가 $223,310.15인 7,105 보통주를 매각할 예정임을 알렸으며, 이는 발행사의 116,897,730 유통 주식의 일부를 차지합니다. 해당 주식은 약 2025-08-18에 NYSE에서 매각될 예정입니다. 제출인은 해당 주식을 restricted stock units으로 2025-08-15에 취득했으며 지급은 N/A로 기재했습니다. 또한 제출서에는 Stephen Rowland가 시행한 이전의 10b5-1 매각 두 건이 기재되어 있는데, 각각 2025-07-15에 7,079주(총수익 $223,446.27)와 2025-06-16에 7,079주(총수익 $244,619.43)입니다.
Klaviyo, Inc. (KVYO) a déposé un avis Form 144 indiquant son intention de vendre 7 105 actions ordinaires pour une valeur marchande totale de $223 310,15, représentant une partie des 116 897 730 actions en circulation de l'émetteur. Les actions devraient être vendues aux alentours du 18/08/2025 sur le NYSE. Le déclarant a acquis les actions sous forme de restricted stock units le 15/08/2025 et indique le paiement comme N/A. Le dépôt divulgue également deux ventes antérieures suivant le mécanisme 10b5-1 effectuées par Stephen Rowland : 7 079 actions le 15/07/2025 (produits bruts $223 446,27) et le 16/06/2025 (produits bruts $244 619,43).
Klaviyo, Inc. (KVYO) meldete ein Form 144, das den geplanten Verkauf von 7.105 Stammaktien mit einem Gesamtmarktwert von $223.310,15 ankündigt, was einen Teil der 116.897.730 ausstehenden Aktien des Emittenten darstellt. Die Aktien sollen voraussichtlich am 18.08.2025 an der NYSE verkauft werden. Der Einreicher hat die Aktien am 15.08.2025 als restricted stock units erworben und gibt die Zahlung als N/A an. Die Einreichung offenbart außerdem zwei frühere 10b5-1-Verkäufe von Stephen Rowland über 7.079 Aktien am 15.07.2025 (Bruttoerlös $223.446,27) und am 16.06.2025 (Bruttoerlös $244.619,43).